134 related articles for article (PubMed ID: 11966752)
1. Does normalization of prolactin levels result in weight loss in patients with prolactin secreting pituitary adenomas?
Yermus R; Ezzat S
Clin Endocrinol (Oxf); 2002 Apr; 56(4):562. PubMed ID: 11966752
[No Abstract] [Full Text] [Related]
2. [Don't miss prolactinoma! On the importance of measuring prolactin and how it is done].
Lindstedt G; Lundberg PA; Jakobsson KE; Tägnfors U; Janson PO
Lakartidningen; 2000 Jan; 97(4):333-6. PubMed ID: 10684228
[TBL] [Abstract][Full Text] [Related]
3. Prolactinoma and body weight: a retrospective study.
Creemers LB; Zelissen PM; van 't Verlaat JW; Koppeschaar HP
Acta Endocrinol (Copenh); 1991 Oct; 125(4):392-6. PubMed ID: 1957557
[TBL] [Abstract][Full Text] [Related]
4. [Structure of an interdisciplinary pituitary outpatient care unit at the University Hospital of Leipzig and results for treatment of prolactin and growth hormone secreting pituitary tumors].
Wiesner TD; Trantakis C; Meixensberger J; Koch CA; Zimmer C; Paschke R
Med Klin (Munich); 2005 Apr; 100(4):173-9. PubMed ID: 15834525
[TBL] [Abstract][Full Text] [Related]
5. [Comparative analysis of surgical and medical treatment of macroprolactinoma of different localization].
Astaf'eva LI; Kadashev BA; Dedov II; Kalinin PL; Kutin MA; Shkaburo AN; Fomichev DV; Tenedieva VD; Tropinskaia OF
Zh Vopr Neirokhir Im N N Burdenko; 2011; 75(4):3-9; discussion 9. PubMed ID: 22379847
[TBL] [Abstract][Full Text] [Related]
6. [Some issues in the diagnosis and treatment of hyperprolactinemia].
Jin ZM
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
[No Abstract] [Full Text] [Related]
7. [Apropos of the article by Ph. Otten et al.: "Prolactin-secreting pituitary adenomas"].
Guy G; Bigorgne JC
Neurochirurgie; 1996; 42(2):123. PubMed ID: 8952906
[No Abstract] [Full Text] [Related]
8. Malignant prolactinoma.
Berezin M; Gutman I; Tadmor R; Horowitz A; Findler G
Acta Endocrinol (Copenh); 1992 Nov; 127(5):476-80. PubMed ID: 1471460
[TBL] [Abstract][Full Text] [Related]
9. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
[TBL] [Abstract][Full Text] [Related]
10. Lower prolactin levels during cabergoline treatment are associated to tumor shrinkage in prolactin secreting pituitary adenoma.
Lombardi M; Lupi I; Cosottini M; Rossi G; Manetti L; Raffaelli V; Sardella C; Martino E; Bogazzi F
Horm Metab Res; 2014 Dec; 46(13):939-42. PubMed ID: 25230324
[TBL] [Abstract][Full Text] [Related]
11. [Pregnancy: a way of recovering from prolactin-secreting adenoma? 18 cases].
Bricaire C; Kerlan V; Kuttenn F; Mauvais-Jarvis P
Presse Med; 1988 Nov; 17(40):2117-9. PubMed ID: 2974140
[TBL] [Abstract][Full Text] [Related]
12. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.
Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH
J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425
[TBL] [Abstract][Full Text] [Related]
13. [Apropos of the article by Ph. Otten et al.: " Pituitary adenomas secreting prolactin"].
Perrin G
Neurochirurgie; 1996; 42(4-5):249-50. PubMed ID: 9084752
[No Abstract] [Full Text] [Related]
14. Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors.
Raverot G; Vasiljevic A; Jouanneau E; Lasolle H
Eur J Endocrinol; 2019 Aug; 181(2):C1-C3. PubMed ID: 31167164
[TBL] [Abstract][Full Text] [Related]
15. Management of prolactin-secreting pituitary adenomas.
Neal JH; Weiss MH
West J Med; 1990 Nov; 153(5):546-7. PubMed ID: 2260295
[No Abstract] [Full Text] [Related]
16. Long-term outcome of multimodal therapy for giant prolactinomas.
Andujar-Plata P; Villar-Taibo R; Ballesteros-Pomar MD; Vidal-Casariego A; Pérez-Corral B; Cabezas-Agrícola JM; Álvarez-Vázquez P; Serramito R; Bernabeu I
Endocrine; 2017 Jan; 55(1):231-238. PubMed ID: 27704480
[TBL] [Abstract][Full Text] [Related]
17. Prolactin-secreting tumors: what's new?
Molitch ME
Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S29-35. PubMed ID: 17004854
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
Smith MV; Laws ER
Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
[TBL] [Abstract][Full Text] [Related]
19. Treatments of multi-invasive giant prolactinoma.
Yang MY; Shen CC; Ho WL
J Clin Neurosci; 2004 Jan; 11(1):70-5. PubMed ID: 14642373
[TBL] [Abstract][Full Text] [Related]
20. 25-hydroxyvitamin D Correlation with Prolactin Levels and Adenoma Size in Female Patients with Newly Diagnosed Prolactin Secreting Adenoma.
Aboelnaga MM; Abdullah N; El Shaer M
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):219-225. PubMed ID: 28595559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
